HSBC TUR.WAR.OP.END. FRE/ DE000HG17JB0 /
20/12/2024 21:36:51 | Diferencia-0.0500 | Bid21:58:03 | Ask21:58:03 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.2200EUR | -3.94% | 1.2100 Volumen de oferta: 10,000 |
1.2400 Tamaño/ Volumen/ Formato de Ask: 10,000 |
FRESENIUS SE+CO.KGAA... | 21.1143 - | 31/12/2078 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página